Rio Tinto plc Stock Price Slides After Cyclone Narelle Shuts Key Queensland Bauxite Mines

Rio Tinto plc Stock Price Slides After Cyclone Narelle Shuts Key Queensland Bauxite Mines

March 21, 2026

LONDON, March 21, 2026, 17:36 UTC

Rio Tinto shares slid on Friday after the company halted operations at its Amrun and Andoom bauxite mines in Northern Queensland, citing Cyclone Narelle’s impact on the region. The Australia-listed stock dropped as much as 4%, touching A$145.36 — a level last seen on Jan. 13.

The shutdown is in focus because the two mines together supply roughly 30 million metric tons of bauxite each year—the raw material for aluminium. Even a brief halt raises questions about deliveries and the upcoming quarter’s profit picture. On Friday in London, Rio Tinto plc closed at 62.46 pounds, according to London Stock Exchange data.

Rio has triggered its cyclone response measures. “We are focused on making sure our people are safe and our operations are secure,” the company said, but it hasn’t specified when things might resume. Reuters

Narelle made landfall on the Queensland coast as a category four, losing strength later the same day. Early damage seemed limited, Premier David Crisafulli noted, but far north Queensland still faced heavy rain, fierce winds and power cuts.

Rio wasn’t the only miner hit. South32 halted work at its Gemco manganese site in the Northern Territory, underscoring how weather threats can ripple fast through northern Australia’s mining sector.

The timing isn’t great. Back in January, Chief Executive Simon Trott pointed to a “step change in bauxite production,” as Rio reported a record 62.4 million tonnes of bauxite output for 2025. Rio Tinto

Investors have been quick to react to bad news lately. In February, Rio’s 2025 underlying earnings landed flat at $10.87 billion, coming in below estimates—lower iron ore prices dulling the impact of copper gains. The stock in London dropped 3.4% that day.

The bauxite market hasn’t found much stability either. Tom Price, who leads commodities at Panmure Liberum, noted that global bauxite prices have slid between 20% and 35% from their 2025 peaks. Guinea, now mulling export quotas, could end up putting more pressure on longer-term demand, he said.

The immediate worry: what starts as a brief safety pause could drag into an extended shutdown if flooding, transport issues, or site repairs derail the timeline. Early official reports indicated cyclone damage appeared limited. Even so, Rio hasn’t committed to a restart date. The London-listed shares? Still down 16.3% from their 52-week peak, despite a 4.2% gain year-to-date.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • Pro Medicus Invests $10M in Echo IQ as Shares Surge 50%
    June 24, 2026, 11:37 PM EDT. Pro Medicus (ASX:PME) has agreed to invest up to $20 million in heart imaging firm Echo IQ (ASX:EIQ), sparking a 50% rise in Echo IQ's shares. The deal includes an initial $10 million via convertible notes and an option for an additional $10 million pending FDA clearance of Echo IQ's Echosolv HF tool, aimed at diagnosing heart failure using AI cardiac ultrasound analysis. Echo IQ's existing FDA-cleared Echosolv AS software targets aortic stenosis. The partnership follows Pro Medicus' successful 2025 collaboration with 4D Medical, which saw strong stock performance post-FDA approval. Echo IQ is now valued above $1 billion. The convertible notes carry a 12.5% interest rate with redemption due in 24 months. Separately, Imagion Biosystems raised $3.75 million to fund an FDA-approved breast cancer imaging trial.